down arrow

Shanghai Pharmaceuticals Holding Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000012B3
HKD
10.97
-0.89 (-7.5%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
83,112.89
84,927.39
75,147.07
80,291.17
76,424.64
75,657.55
70,966.32
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
83,112.89
84,927.39
75,147.07
80,291.17
76,424.64
75,657.55
70,966.32
Raw Material Cost
74,244.42
76,317.07
66,919.58
72,652.38
68,622.58
68,375.49
63,394.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
412.51
392.29
444.46
429.45
478.65
474.80
508.21
Selling and Distribution Expenses
5,188.83
5,024.90
5,010.16
4,858.43
4,894.27
4,241.12
4,520.01
Other Expenses
10.82
7.94
37.01
8.91
-5.69
-1.94
27.25
Total Expenditure (Excl Depreciation)
79,953.95
81,813.62
72,744.26
78,029.36
73,938.56
73,072.00
68,695.35
Operating Profit (PBDIT) excl Other Income
3158.8999999999996
3113.8
2402.8
2261.8
2486.1000000000004
2585.6
2271
Other Income
1,199.75
262.37
175.37
288.12
3,518.62
100.95
370.30
Operating Profit (PBDIT)
5,018.43
3,870.71
2,957.44
2,761.29
6,081.98
3,283.44
2,832.30
Interest
412.51
392.29
444.46
429.45
478.65
474.80
508.21
Exceptional Items
-68.44
69.29
240.20
40.85
40.95
40.42
-182.57
Gross Profit (PBDT)
8,868.47
8,610.32
8,227.50
7,638.79
7,802.06
7,282.07
7,571.73
Depreciation
865.27
848.29
869.94
866.60
785.33
778.19
733.97
Profit Before Tax
3,672.21
2,699.42
1,883.25
1,506.10
4,858.95
2,070.87
1,407.54
Tax
829.47
642.18
585.91
530.96
1,417.26
547.98
571.99
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,401.82
1,599.84
633.46
752.00
3,372.68
1,425.29
538.93
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,401.82
1,599.84
633.46
752.00
3,372.68
1,425.29
538.93
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
466.00
487.87
449.82
331.27
246.87
328.37
376.73
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,867.83
2,087.71
1,083.28
1,083.27
3,619.55
1,753.65
915.67
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.16
1.13
1.11
1.09
1.1
1.07
1.06
Reserves
90,548.62
87,729.91
84,528.83
82,829.97
82,269.33
78,332.71
76,278.06
Earnings per share (EPS)
0.65
0.43
0.17
0.2
0.91
0.38
0.15
Diluted Earnings per share
0.65
0.43
0.17
0.2
0.91
0.38
0.15
Operating Profit Margin (Excl OI)
3.55%
3.25%
2.54%
2.0%
2.33%
3.18%
2.43%
Gross Profit Margin
5.46%
4.18%
3.66%
2.96%
7.39%
3.77%
3.02%
PAT Margin
2.89%
1.88%
0.84%
0.94%
4.41%
1.88%
0.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is -2.14% vs 13.01% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 37.37% vs 92.72% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 5.83% vs 29.70% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 5.15% vs -11.74% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Shanghai Pharmaceuticals Holding Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
83,112.89
617.00
82,495.89
13,370.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
83,112.89
617.00
82,495.89
13,370.48%
Raw Material Cost
74,244.42
98.34
74,146.08
75,397.68%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
412.51
12.51
400.00
3,197.44%
Selling and Distribution Expenses
5,188.83
390.09
4,798.74
1,230.16%
Other Expenses
10.82
3.47
7.35
211.82%
Total Expenditure (Excl Depreciation)
79,953.95
535.60
79,418.35
14,827.92%
Operating Profit (PBDIT) excl Other Income
3,158.94
81.40
3,077.54
3,780.76%
Other Income
1,199.75
2.00
1,197.75
59,887.50%
Operating Profit (PBDIT)
5,018.43
106.27
4,912.16
4,622.34%
Interest
412.51
12.51
400.00
3,197.44%
Exceptional Items
-68.44
0.00
-68.44
Gross Profit (PBDT)
8,868.47
518.65
8,349.82
1,609.91%
Depreciation
865.27
25.29
839.98
3,321.39%
Profit Before Tax
3,672.21
68.47
3,603.74
5,263.24%
Tax
829.47
7.14
822.33
11,517.23%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
2,401.82
57.69
2,344.13
4,063.32%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,401.82
57.69
2,344.13
4,063.32%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
466.00
3.90
462.10
11,848.72%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,867.83
61.59
2,806.24
4,556.32%
Equity Capital
0
0
0.00
Face Value
1.16
0.00
0.00
Reserves
90,548.62
1,662.55
88,886.07
5,346.37%
Earnings per share (EPS)
0.65
0.02
0.63
3,150.00%
Diluted Earnings per share
0.65
0.02
0.63
3,150.00%
Operating Profit Margin (Excl OI)
3.55%
12.80%
0.00
-9.25%
Gross Profit Margin
5.46%
15.20%
0.00
-9.74%
PAT Margin
2.89%
9.35%
0.00
-6.46%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 8,311.29 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -2.14% vs 13.01% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 8.75% vs 2.50% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 286.78 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 37.37% vs 92.72% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -20.77% vs 93.61% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 381.87 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.83% vs 29.70% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 48.97% vs -24.12% in Jun 2025

Quarterly - Interest
Interest 41.25 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.15% vs -11.74% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -13.81% vs -0.62% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 3.55%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading